Encysive Drug Study Comes to an End
Encysive Pharmaceuticals today announced topline results from the Company's multi- center, pivotal Phase III STRIDE-2 (Sitaxsentan To Relieve ImpaireD Exercise)…
Part of the
network
network
Tag: Placebo
